- Adjusted EBITDA increased slightly to $125.4 million from $124.7 million year-over-year.
- Adjusted EBITDA margin for inpatient rehab declined slightly to 22.6% from 23.1%.
- Consolidated revenue grew nearly 5% to $1.3 billion in Q2 2025.
- Critical illness recovery hospital division revenue declined 1% to $601.1 million; adjusted EBITDA declined 22% year-over-year with margin at 9.4% versus 11.9% prior year.
- Earnings per common share from continuing operations rose 88% to $0.32 from $0.17.
- Inpatient rehab hospital division revenue rose 17% year-over-year to $313.8 million with adjusted EBITDA up nearly 15% to $71 million.
- Interest expense was $30 million in Q2 compared to $28 million prior year.
- Operating cash flow generated $110.3 million; investing activities used $64.7 million; financing activities used $46.5 million including $85.1 million in share repurchases.
- Outpatient rehab division revenue increased 3.8% driven by a 3.8% increase in patient volume; adjusted EBITDA increased 6.1% with margin improving to 9.3% from 9.1%.
- Salary, wage and benefits to revenue ratio in critical illness division rose slightly to 58%.
Related items and other data are not available for this feed item.
Dafinchi